Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1481 |
|---|---|
| Identifier | NCT02760615 |
| Trial Title | Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative|Crohn Disease |
| Interventions | DRUG: Caffeine|DRUG: Losartan|DRUG: Omeprazole|DRUG: Dextromethorphan|DRUG: Midazolam|DRUG: Vedolizumab |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Cypress |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2016-11-01 |
|---|---|
| Primary Completion Date | 2020-08-01 |
| Completion Date | 2020-08-01 |